Bernd Seizinger
CHAIRMAN
Management
Oxford BioTherapeutics
Spain
Biography
Dr Seizinger has held a number of senior executive and board positions in both U.S. and European biotech and pharmaceutical companies (public and private) including: President & CEO of GPC Biotech (Germany/U.S.); VP Oncology Drug Discovery & Molecular Genetics, and VP Corporate and Academic Alliances at Bristol-Myers-Squibb (U.S.); EVP/CSO of Genome Therapeutics (U.S.); CEO/Chairman of CryptoMedix (U.S.); Executive Chairman/Chairman of Aprea (Sweden/U.S.); and Executive/Chairman of Opsona (Ireland). Prior to his corporate appointments, Dr Seizinger held senior faculty positions at Harvard Medical School and Massachusetts General Hospital, and was a Visiting Professor at Princeton University during his tenure at Bristol-Myers Squibb.
Research Interest
pharmaceutical
